Evidence map›Paper›PMID 28917812›Full record

ArticleMagnetic resonance imaging2018

A minimum-phase Shinnar-Le Roux spectral-spatial excitation RF pulse for simultaneous water and lipid suppression in

Paul Kyu Han, Chao Ma, Kexin Deng, Shuang Hu, Kyung-Wook Jee, Kui Ying, Yen-Lin Chen, Georges El Fakhri

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Magnetic resonance imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Paul Kyu HanGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Chao MaGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Kexin DengBiomedical Engineering, Tsinghua University, Beijing, People's Republic of China.
Shuang HuGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Department of Nuclear Medicine, West China Hospital, Sichuan University, Sichuan, People's Republic of China.
Kyung-Wook JeeDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Kui YingEngineering Physics, Tsinghua University, Beijing, People's Republic of China.
Yen-Lin ChenGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Georges El FakhriGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: elfakhri.georges@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · USTsinghua University · CNGordon Center for Medical Imaging · US

Funding

Unified Joint Statistical Reconstruction of PET & MRP41EB022544 · NIBIB · YALE UNIVERSITY · PI Georges El Fakhri · 2017 to 2026
$14.8M
Quantitative Oncologic PET-MRR01CA165221 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2012 to 2023
$4.7M
Postgraduate Training Program in Medical Imaging (PTPMI)T32EB013180 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Ciprian Catana, Pedram Heidari · 2011 to 2026
$3.7M
PET/MR Mapping of Myocardial Membrane PotentialR01HL137230 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2017 to 2020
$3.3M
PET/MRS guided radiotherapyR21EB021710 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2016 to 2017
$470k
PROTON THERAPY RESEARCH AND TREATMENT CENTERC06CA059267 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GOITEIN, MICHAEL · 1992 to 1995
–
NCI NIH HHS C06 CA059267NCI NIH HHS R01 CA165221NHLBI NIH HHS R01 HL137230NIBIB NIH HHS P41 EB022544NIBIB NIH HHS R21 EB021710NIBIB NIH HHS T32 EB013180
6 · The paper itself

Abstract

purposeTo develop a spectral-spatial (SPSP) excitation RF pulse for simultaneous water and lipid suppression in proton (

methodsAn SPSP excitation pulse is designed to excite Creatine (Cr) and Choline (Cho) metabolite signals while suppressing the overwhelming water and lipid signals. The SPSP pulse is designed using a recently proposed multidimensional Shinnar-Le Roux (SLR) RF pulse design method. A minimum-phase spectral selectivity profile is used to minimize signal loss from T

resultsThe performance of the SPSP pulse is evaluated via Bloch equation simulations and phantom experiments. The feasibility of the proposed method is demonstrated using three-dimensional, short repetition-time, free induction decay-based

conclusionThe proposed SPSP excitation pulse is useful for simultaneous water and lipid suppression. The proposed method enables new applications of high-resolution

Indexed as

AlgorithmsHumansImage Processing, Computer-AssistedLegLipidsMagnetic Resonance SpectroscopyMuscle, SkeletalPhantoms, ImagingProtonsWaterLipidsProtonsWater(1)H-MRSILipid suppressionMultidimensional SLR pulseSpectral-spatial pulseWater suppression

Identifiers

PMID28917812
PMCPMC5709164
OpenAlexW2754197675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.